Pull to refresh
Logo
Daily Brief
Following
Why Ranks Sign Up
Marc N. Casper

Marc N. Casper

Chairman and Chief Executive Officer, Thermo Fisher Scientific

Appears in 1 story

Notable Quotes

"Clario is an outstanding strategic fit for our company, enhancing our ability to enable faster, more informed drug development through differentiated technology and data intelligence solutions." — upon announcing the deal

"We've long admired Clario and this acquisition underscores our disciplined capital deployment strategy, which has an outstanding track record of creating shareholder value."

Stories

Thermo Fisher completes nearly $9 billion acquisition of clinical trial data company Clario

Money Moves

Leading post-acquisition integration

Thermo Fisher Scientific, one of the world's largest scientific instrumentation companies, closed its $8.875 billion cash purchase of Clario Holdings on March 24, 2026. The deal, first announced in October 2025, includes up to $525 million in additional payments tied to Clario's near-term performance, bringing the potential total to $9.4 billion.

Updated May 30